Caution is needed with a history of pancreatitis, gallbladder disease, severe gastrointestinal conditions such as gastroparesis, diabetic retinopathy, or certain other medications, including insulin and sulfonylureas
PlexusDx's Precision Peptide Genetic Test can identify whether variants in your GIPR gene (rs1800437) suggest you might tolerate GIP-receptor activation better, informing your provider's choice between semaglutide and tirzepatide
The current standard treatment CPAP has several disadvantages, including low compliance, reliance on hospital-based clinic devices, and potential weight gain, which is not conducive to long-term disease control [24]
F., Battaglia, G., Palma, A., & Paoli, A
Glucagon is usually thought of as a glucose- raising hormone, but in the context of simultaneous GLP-1/GIP agonism the net effect studied in trials was increased energy expenditure alongside strong glycemic control a combination that appears to explain the outsized weight effect observed in the research
Compounded GLP-1 medications are not FDA-approved and are not available in all states